| Jul 26 |
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
|
| Jul 18 |
All You Need to Know About Insulet (PODD) Rating Upgrade to Strong Buy
|
| Jul 12 |
Should You Be Impressed By Insulet Corporation's (NASDAQ:PODD) ROE?
|
| Jul 8 |
Insulet to Announce Second Quarter 2024 Financial Results on August 8, 2024
|
| Jul 5 |
(PODD) - Analyzing Insulet's Short Interest
|
| Jun 25 |
Insulet Points Its Insulin Pump at the Big Diabetes Market: Type 2
|
| Jun 25 |
ESLOY vs. PODD: Which Stock Is the Better Value Option?
|
| Jun 24 |
Lilly Weight-Loss Drug Data Spurs Selloff in Sleep Apnea Stocks
|
| Jun 24 |
Insulet's (PODD) Omnipod 5 Favored in Study for Type 2 Diabetes
|
| Jun 24 |
Insulet seeks label expansion of Omnipod 5 for Type 2 diabetes
|
